Chemotherapy and the development of novel therapeutics
|
|
- Jesse Mason
- 5 years ago
- Views:
Transcription
1 SCPA607-Pathobiology and mechanisms of cancer Chemotherapy and the development of novel therapeutics Somphong Narkpinit, M.D. Department of Pathobiology Faculty of Science Mahidol University somphong.nar@mahidol.ac.th
2 Aim of session - Understand Cell Cycle - Chemotherapy and the cancer cell - Side effects - Administration & safety
3 Definition : Chemotherapy The treatment of cancer using specific chemical agents or drugs that are destructive to malignant cells and tissues. The term comes from two words that mean "chemical" and "treatment." Cytotoxic literally translated means toxic to cells.
4 The Cell Cycle The Cell Cycle
5 Mitosis DNA Replication Prophase Metaphase Anaphase Cytokinesis Telophase
6 A cell in mitosis Cell Biology: Mitosis
7 Normal Cell Characteristics: Metabolism. Strictly controlled & predictable Maturation & Specialisation. Occurs before dividing. Strictly controlled. Contact Inhibition. Mechanism for switching off division when in contact with different cells Recognition. Like cells stay together.
8 Cancer Cell Characteristics: Unchecked & Uncontrolled Growth Loss of contact inhibition Loss of capacity to differentiate Increased growth fraction Chromosomal Instability Capacity to metastasise Altered biochemical properties
9 Chemotherapy Drugs transported via blood Reduce size of tumor for surgical removal or for palliation Prophylaxis to prevent recurrence of cancer Growth fraction: # tumor cells undergoing mitosis
10 Chemotherapy administration Intravascular peripheral versus central lines Oral Intramuscular Intra cavity
11 Cell cycle Tumor cells similar to non-cancerous cells Neoplastic and normal cell differ in the number of cells undergoing cell division Cancer cells lack normal mechanism of suppressing cell growth Anti-cancer drugs target cells that are dividing
12 Chemotherapy Interfere with DNA, RNA, or protein synthesis S-phase specific Inhibit microtubule formation during mitosis M-phase
13 Chemotherapy Damage DNA Cell-cycle non-specific DNA alkylating agents damage tumor cells whether dividing or not
14 Combination Chemotherapy Each drug active against the cancer Different site of action Different toxicity levels If similar, toxic levels occur at different times Nadirs different times
15 Chemotherapy and Cancer Cells Cell Cycle specific : Most active against cells in a specific phase therefore need prolonged exposure or repeated doses. Cell Cycle Non-specific: Most effective against actively dividing cells but also effective in G0.
16 Chemotherapy Chemotherapy may be used conventionally to: - Cure patients - Prolong survival - Palliative care symptom control
17 Chemotherapy - Combination Therapy. - Prevents resistance. - Adjuvant Therapy. - Administered after primary therapy e.g.surgery - Neo adjuvant Therapy: Given before surgery to reduce tumour size.
18 Chemotherapy - Over 50 different chemotherapy drugs - Administered as an outpatient or inpatient depending on toxicity - Modes of administration include: Oral e.g. Methotrexate, Hydroxyurea - IV: Canula/Indwelling Central Venous Catheter - Sub cut - Intracavity e.g pelvic cavity, bladder - Intrathecal. Can be fatal if wrong drug administered!
19 Intrathecal Chemotherapy
20 Ankylating agents Mechanism of action
21 Ankylating agents Mechanism of action - Cell-cycle non-specific - Works on: - Already formed DNA - Cross-linked strands - Prevents replication
22 Alkylating Agents - Nitrogen mustard - Cyclophosphamide (Cytoxan) - Chlorambucil (Leukeran) - Cis-platin (platinol) - Ifosfamide - Dacarbazine
23 Alkylating agents - Nursing - Blood dyscrasias - Report any buzzing, ringing in ears (loss of high-freq hearing) - s/s allergic reaction
24 Alkylating agents - Nursing - Blood counts - GI mucosa nutrition important - Skin blistering - Renal/ liver function tests - Can cause sterility use contraception
25 Alkylating agents Interactions - Immunosuppressants increase infection - Anticoagulants bleeding - Digoxin decrease dig effect - Thiazides - leukopenia
26 Antimetabolites - Methotrexate - 5-fluorouracil - Cytosine arabinoside - Cytarabine (Ara-C) - Thioguanine
27 Antimetabolites - Cell-cycle specific (S-phase) - Inhibit protein synthesis - Interferes with DNA synthesis
28 Antimetabolites - Nursing - Most toxicity in hematopoietic and GI systems bone marrow stem cells and GI epithelium - Renal/ Liver function tests - s/s respiratory infection
29 Antimetabolites - Interactions - Decreases Digoxin - Affects protein bound drugs (ASA, dilantin) - NSAIDs, ASA increase toxicity - Other chemo agents/ radiation increase effect
30 Anti-Metabolite: Methotrexate - Leucovorin rescue - Form of folic acid - Treats systemic toxic effects - Administer within the first hours
31 Cytotoxic antibiotics
32 Cytotoxic antibiotics - Doxorubicin (adriamycin) - Bleomycin - Danorubicin - Idarubicin
33 Cytotoxic antibiotics - Cell-cycle non-specific - Interfere with nucleic acid synthesis - Inhibit DNA & RNA synthesis
34 Cytotoxic antibiotics - Nursing Most toxicities occur: - Hematopoietic - GI - Reproductive - Cardiac
35 Cytotoxic antibiotics - Nursing Vesicant drugs Assess: - Pain - Redness - Swelling - Ulceration
36 Cytotoxic antibiotics Interactions Digoxin decrease dig level Phenobarbital decreased chemo effectiveness Dilantin decrease dilantin level
37 Plant alkaloids
38 Plant Derivations - Periwinkle - Pacific yew - Mandrake - Campthecus acuminata Mandrake Periwinkle Pacific Yew
39 Plant alkaloids - Etopside (VP-16) - Paclitaxel (Taxol) - Vincristine (Oncovin) - Vinblastine - Vinorebline
40 Plant alkaloids - Cell-cycle specific (M-phase) - Arrest metaphase by binding to cell proteins
41 Plant alkaloids - Nursing - Check of allergies to plants prior to administration - Assess for bronchospasms - Can lower seizure threshold - Nutritional plan to combat constipation - Assess mental status depression
42 Plant alkaloids Interactions - Dependent on drug - Calcium channel blockers increase Vincristine effect - Digoxin decrease dig effect - Dilantin decrease dilantin effect
43 Chemotherapy Side Effects - Chemotherapy targets cells which are dividing rapidly. - Chemotherapy cannot distinguish between normal cells and cancer cells - Healthy Cells which have a high rate of growth and multiplication include cells of the bone marrow, hair, GI mucosa and skin.
44 Chemotherapy Side effects contd - Side effects may be drug specific e.g. anthracyclines and cardiotoxicity, vinca alkaloids and neuropathy/constipation, bleomycin and pulmonary fibrosis - Severity of side effects varies between drugs. - Side effects often occur 7-14 days post treatment.
45 Side Effects - General B bone marrow suppression A alopecia R retching F fatigue
46 Skin - Alopecia - From thin wispy pattern to total loss of hair - Hair regrows: - Thicker - Wavier - Darker color
47 Side Effects: Acute - Tumour Lysis Syndrome. - A Metabolic Emergency. - Occurrs due to rapid cell lysis (death) & large amounts of cell metabolites in blood. - If untreated can lead to acute renal failure, cardiac arrest and death.
48 Hematological - Neutropenia - Leukopenia - Thrombocytopenia - Anemia - Fatigue - Risk for infection - Risk for bleeding
49 Side Effects: Acute - Neutropenic Sepsis: - Occurs due to Bone Marrow Failure and poor immune response to infection. - Predisposing factors include: - Neutropenia - Underlying disease - Chemotherapy - Venous access devices
50 Neutropenic Sepsis - Severe overwhelming infection where inadequate blood flow to the tissues results in cellular dysfunction and, if not reversed, eventual organ failure. - Most common micro organism is gram negative - Mortality rate 40-90%
51 Side Effects: Gastro-Intestinal Nausea & Vomiting Diarrhoea & constipation Loss of appetite Taste Changes Mucositis
52 Hepatic Hepatic toxicity
53 Mucosal tissue - Stomatitis - Ulcerating lesions on mucosa - Burning sensation with fluids - Pain to oral or esophageal mucosa - Nutrition poor no appetite
54 Side Effects Example of Grade 4 Mucositis
55 Side Effects: Body Image Hair Loss Weight Loss/ Weight Gain Long term central venous catheters Skin changes (colour, rashes, sensitivity to sunshine/ chlorine, dry)
56 Neurological - Parasthesia - Motor weakness - fatigue - Paralytic ileus - Changes in hearing (high dose Cisplatin)
57 Urinary - Hemorrhagic cystitis - Renal toxicity - Purines released during cell destruction converted to uric acid crystals
58 Cardiotoxicity - Rare occurrence - Cardiac- toxicity - Pulmonary toxicity - EKG changes
59
60 Pulmonary Toxicity
61 Reproductive - Infertility - Cause birth defects - Cause sterility or decrease sperm
62 Emotional - Anticipatory grief - Anger - Anxiety - Depression - Guilt
63 Key Points: - Chemotherapy is a major treatment in curing or prolonging survival in cancer patients - It has a wide range of side effects depending on the drugs given. - Nurses have a key role to play in caring for a patient receiving chemotherapy - Safety issues are paramount in administration. - The potential benefit to the patient of treatment as an option must always outweigh the toxic effects
64
Antineoplastic Drugs. Antineoplastic Drugs. Herbal Alert. Pharmacology Chapter 51. Green tea
Antineoplastic Drugs Pharmacology Chapter 51 Carolyn Wright, RN, BSN Ford, S. & Roach, S. (2010). Roach's introductory clinical pharmacology (9 th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams
More informationHospice Skills Checklist
_ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values
More informationOncology Skills Checklist
_ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values
More informationMedication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication
More informationDRUGS FOR NEOPLASIA. Chapter 37
DRUGS FOR NEOPLASIA Chapter 37 Keywords- You tell Me! Cancer dz characterized by abnormal, uncontrolled cell division Tumor swelling, abnormal enlargement or mass of tissue Carcinogen any substance or
More information2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation) 3. Antimetabolites (anti-folates, pyrimidine and purine analogues)
CANCER DRUG CLASSES The classes of drugs currently used in the cancer clinic are 1. DNA Binding Agents (intercalating and alkylating agents) 2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation)
More informationChapter 37. Media Directory. Tumor (neoplasm) Cancer (carcinoma) Causes of Cancer. Drugs for Neoplasia
Chapter 37 Media Directory Drugs for Neoplasia Slide 39 Slide 41 Cyclophosphamide Animation Methotrexate Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cancer (carcinoma) Tumor (neoplasm)
More informationCancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018
Cancer Chemotherapy Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 االدوية Polyfunctional Alkylating Agents االستخالبية متعددة الوظائف Not cell cycle-specific.
More informationthrough the cell cycle. However, how we administer drugs also depends on the combinations that we give and the doses that we give.
Hello and welcome to this lecture. My name is Hillary Prescott. I am a Clinical Pharmacy Specialist at The University of Texas MD Anderson Cancer Center. My colleague, Jeff Bryan and I have prepared this
More informationDRUG EXTRAVASATION. Vesicants. Irritants
DRUG EXTRAVASATION Vesicants Irritants Vesicants Antineoplastic drugs Amsacrine Dactinomycin Daunorubicin Docetaxel (rare) Doxorubicin Epirubicin Idarubicin Mechlorethamine Mitomycin Oxaliplatin (rare)
More informationStem cell transplantation. Dr Mohammed Karodia NHLS & UP
Stem cell transplantation Dr Mohammed Karodia NHLS & UP The use of haemopoeitic stem cells from a donor harvested from peripheral blood or bone marrow, to repopulate recipient bone marrow. Allogeneic From
More informationChemotherapy and its side effects.
Chemotherapy and its side effects. Maria Ronson Lead Chemotherapy Nurse Learning outcomes How it works on cells terminology. Understand and learn about side effects of chemotherapy. Management of side
More informationCancer Incidence and Mortality
Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it. The cure rate is 50% Cancer is strongly age-related, the
More informationYear III Pharm D. Dr. V. Chitra
Year III Pharm D. Dr. V. Chitra 50.2 Rang Etiolopathology Cell Cycle = Growth, Division 18_01_cell_cycle.jpg Characteristics of Cancer Cells The problem: Cancer cells divide rapidly (cell cycle is accelerated)
More informationPrinciples of chemotherapy
Principles of chemotherapy Chemotherapy first coined by Paul Ehrlich Aim to selectively destroy cancer cells whilst relatively sparing tumours cells Growth characteristics of cancer cells allows for selective
More informationAnti-cancer drugs. Introduction : Body : 1) Alkylating Agents
Anti-cancer drugs Introduction : In this journal I will try to explain what is anti-cancer agents, how they work, how can they inhibit the growth of tumor and what is the advantages and disadvantages of
More informationOncology Competency Self Assessment
Oncology Competency Self Assessment Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values confirm your
More information*Combination therapy: *Cancer drugs are divided into groups: I) DNA binding agents (Intercalating and Alkylating agents) 2 types: Doxorubicin
*Combination therapy: - Cancer is heterogeneous, and resistant anticancer drugs are common, so combination of drugs together is needed in order to attack cancer. *Cancer drugs are divided into groups:
More informationCancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018
Cancer Chemotherapy Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 Modalities of Cancer Chemotherapy Curative: Only in 10-15% of cases. In certain disseminated
More information"Pharmacology. Anticancer Drugs
I "Pharmacology Anticancer Drugs Include: 1) Cytotoxic drugs. 2) Isotopes: which emit β-irradiation that destroy cancer cells, e.g. I 131, P 32, Au 193 3) Hormones: A- Steroids: prednisolone used in leukemia
More informationBreast Pathway Group EC x 4 Paclitaxel x 4 (3-weekly): Epirubicin & Cyclophosphamide x 4 followed by Paclitaxel x 4 (3-weekly) in Early Breast Cancer
Breast Pathway Group EC x 4 Paclitaxel x 4 (3-weekly): Epirubicin & Cyclophosphamide x 4 followed by Paclitaxel x Indication: Neoadjuvant or adjuvant therapy for moderate to high risk node positive breast
More informationBreast Pathway Group EC x 4: Epirubicin & Cyclophosphamide in Early Breast Cancer
Breast Pathway Group EC x 4: & in Early Breast Cancer Indication: Neoadjuvant or adjuvant treatment for moderate to high risk breast cancer Regimen details: 90 mg/m 2 IV Day 1 600 mg/m 2 IV Day 1 Administration:
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 20
Figure 20-1 Figure 20-2 Figure 20-3A Figure 20-3B Figure 20-4 Table 20-1 Antineoplastic Agents Used for Chemotherapy in Animals Drug Type Drug Category Examples Cell-Cycle Effect CCNS Alkylating agents:
More informationElements for a Public Summary. Overview of Disease Epidemiology
VI.2 VI.2.1 Elements for a Public Summary Overview of Disease Epidemiology Toxicity of Folic acid antagonists Despite having a low frequency of major toxicity, low dose Methotrexate (MTX, folic acid antagonist)
More informationPfizer Laboratories (Pty) Ltd P&U Etoposide CSV Range Approved PI: 12 Sep 2005 Page 1 of 5
Approved PI: 12 Sep 2005 Page 1 of 5 SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): P&U ETOPOSIDE CSV 100 mg/5 ml INJECTION (INJECTION CONCENTRATE FOR INTRAVENOUS INFUSION) P&U ETOPOSIDE CSV
More informationAdverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and
35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting
More informationFEC-D with HP Fluorouracil, Epirubicin, Cyclophosphamide, Followed by Docetaxel, Trastuzumab, Pertuzumab Neoadjuvant Protocol
Approved for use in: Neoadjuvant breast cancer: The neoadjuvant treatment of HER2 positive locally advanced, inflammatory or early breast cancer at high risk of recurrence Interim CDF funding from November
More informationCPAG Summary Report for Clinical Panel Policy 1630 Bendamustine-based chemotherapy for first-line treatment of Mantle cell lymphoma (MCL) in adults
MANAGEMENT IN CONFIDENCE CPAG Summary Report for Clinical Panel Policy 1630 Bendamustine-based chemotherapy for first-line treatment of Mantle cell lymphoma (MCL) in adults The Benefits of the Proposition
More informationAzathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS
Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Only valid for adult patients Azathioprine must be at a dose of at least
More informationCancer SLO Practice (online set) Page 1 of 5
Cancer SLO Practice (online set) Page 1 of 5 1. Aranesp is? A. Darbepoetin alfa B. Filgrastim C. Epoetin alfa D. Sargramostim E. Pegfilgrastim 2. BCNU is? B. Cyclophosphamide 3. Bleomycin is a natural
More informationBreast Pathway Group FEC75 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer
Breast Pathway Group FEC75 (Fluorouracil / Epirubicin / Cyclophosphamide) in Early Breast Cancer Indication: Neoadjuvant or adjuvant therapy in early breast cancer Regimen details: Fluorouracil 600mg/m
More informationCisplatin and Gemcitabine (bladder)
Cisplatin and Gemcitabine (bladder) Indication Palliative therapy for locally advanced or metastatic bladder cancer in patients with good renal function. Palliative therapy for urothelial transitional
More informationNECN CHEMOTHERAPY HANDBOOK PROTOCOL
DRUG ADMINISTRATION SCHEDULE Day Drug Dose Route Diluent Rate 1* to 5 Prednisolone 40mg/m 2 Oral Once Daily For 5 days 1 Paracetamol 1gram Oral Once Only Chlorphenamine 10mg IV bolus Ondansetron 8mg IV
More informationCancer Incidence and Mortality
Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it. The cure rate is 50% Cancer is strongly age-related, the
More informationTHE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST
Outpatient Anti Cancer Treatment Handbook LCV Lomustine, Cisplatin, Vincristine Packer Regimen Repeated every 6 weeks for a maximum of 6 cycles Approved for use in: Medulloblastoma adjuvant therapy Dosage:
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Doxorubicin 2mg/ml Concentrate for solution for infusion Referred to in this leaflet as Doxorubicin 2mg/ml
PACKAGE LEAFLET: INFORMATION FOR THE USER Doxorubicin 2mg/ml Concentrate for solution for infusion Referred to in this leaflet as Doxorubicin 2mg/ml Read all of this leaflet carefully before you start
More informationCABAZITAXEL Prostate Cancer
Systemic Anti-Cancer Treatment Protocol CABAZITAXEL Prostate Cancer PROCTOCOL REF: MPHACABAZ (Version No: 1.0) Approved for use in: Cabazitaxel in combination with prednisolone is a treatment option for
More information3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis
Chapter 56 Care of the Patient with Cancer All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Cancer Rates in the US 1 in 2 men and 1 in 3 women
More informationCHEMOTHERAPY/ ANTICANCER DRUGS/ NEOPLASTIC AGENTS
CHEMOTHERAPY/ 1 Oncology, Misc, Vaccines ANTICANCER DRUGS/ NEOPLASTIC AGENTS Important Terms: Cancer: A group of diseases involving abnormal cell growth with the potential to invade or spread to other
More informationPrinciples of chemotherapy. Ann De Becker Klinische Hematologie UZ Brussel
Principles of chemotherapy Ann De Becker Klinische Hematologie UZ Brussel History Paul Ehrlich (1854-1915) 1909 Arsphenamine for syphilis treatment Definition: Use of any drug to cure any disease Antineoplastic/cytotoxic
More informationCell Cycle Phase. Interphase (G 1, S, G 2 ) Mitotic Phase (M phase) Prophase. Metaphase. Anaphase. Telophase
Part I: The Cell Cycle Use your resources at hand and the Explore Student Guide to outline what occurs within the cell during each stage of the cell cycle. Record this information in Table 1 below. Cell
More informationDBL VINBLASTINE INJECTION
DBL VINBLASTINE INJECTION NAME OF MEDICINE Vinblastine Injection DESCRIPTION DBL Vinblastine Sulfate B.P. is the sulfate of an alkaloid, occurring in the Vinca rosea Linn., (a common, flowering herb).
More informationWhy do cells reproduce?
Outline Cell Reproduction 1. Overview of Cell Reproduction 2. Cell Reproduction in Prokaryotes 3. Cell Reproduction in Eukaryotes 1. Chromosomes 2. Cell Cycle 3. Mitosis and Cytokinesis Examples of Cell
More informationEssentials. Oncology Practise Essentials. Oncology Basics. Tutorial 2. Cancer Chemotherapy
Practise Practise This tutorial introduces you to the history, goals of therapy, classification, and clinical uses of chemotherapy. It also reviews some of the barriers to successful therapy. Goals and
More informationAngCN Chemotherapy Core Education Package Part B Worksheets for Modules 1-7
AngCN-CCG-C13 AngCN Chemotherapy Core Education Package Part B Worksheets for Modules 1-7 AngCN would like to acknowledge and thank the AngCN Chemotherapy Nurses Group for their efforts in the production
More informationAnticancer Drugs. Cytotoxic drugs Antineoplastic agents
Anticancer Drugs Cytotoxic drugs Antineoplastic agents 1 Principles of Cancer Chemotherapy Cancer chemotherapy strives to cause a lethal cytotoxic event or apoptosis in the cancer cells that can arrest
More informationBreast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Cancer
Breast Pathway Group EC x 4 Docetaxel x 4: Epirubicin & Cyclophosphamide followed by Docetaxel in Early Breast Indication: Neoadjuvant therapy for high risk and fit breast cancer patients suitable for
More informationChemotherapy Teaching Points
Chemotherapy Teaching Points 1. Antimetabolites - These drugs are analogs of vital co-factors in DNA or RNA synthesis. They competitively inhibit DNA or RNA production, or are directly incorporated into
More informationPVACE-BOP (Hodgkin s Lymphoma)
DRUG ADMINISTRATION SCHEDULE Day Drug Dose Route Diluent Rate 1 Ondansetron 8mg IV / Oral vinblastine 6mg/m 2 (Max: 10mg) IV Infusion Etoposide 100mg/m 2 IV infusion Patients over 65 years by 15 min infusion
More informationCISPLATIN Chemo-radiation regimen Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol CISPLATIN Chemo-radiation regimen Gynaecological Cancer PROCTOCOL REF: MPHAGYNCIX (Version No: 1.0) Approved for use in: Locally advanced cervical cancer (adjuvant/curative)
More informationAnticancer Drugs. Cytotoxic drugs Antineoplastic agents
Anticancer Drugs Cytotoxic drugs Antineoplastic agents 1 Principles of Cancer Chemotherapy Cancer chemotherapy strives to cause a lethal cytotoxic event or apoptosis in the cancer cells that can arrest
More informationPEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH
PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP Denise Rokitka, MD, MPH Objectives Describe incidence of childhood cancer and survival rates and causes of early mortality. Understand the late effects of cancer
More informationR-IDARAM. Dexamethasone is administered as an IV infusion in 100mL sodium chloride 0.9% over 30 minutes.
R-IDARAM Indication Secondary CNS lymphoma ICD-10 codes Codes with a prefix C85 Regimen details Day Drug Dose Route 1 Rituximab 375mg/m 2 IV infusion 1 Methotrexate 12.5mg Intrathecal 1 Cytarabine 70mg
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: TAG IDAG Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationPharmacology. Cell cycle
Objectives: To define chemotherapy To define the common classes of drugs used and mechanism of action To identify dermatologic side effects of chemotherapeutic drugs Chemotherapy Definition: the treatment
More informationBC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine
BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine Protocol Code Tumour Group Contact Physician UGOOVBEVV Gynecologic Oncology Dr.
More informationChapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders
Chapter 28 Drugs for Hematopoietic Disorders Slide 35 Media Directory Epoetin Alfa Animation Upper Saddle River, New Jersey 07458 All rights reserved. Hematopoiesis Figure 28.1 Hematopoiesis Process of
More informationDERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:
OBINUTUZUMAB+CHLORAMBUCIL Regimen RDH; Day 1 and 2 Dose to be given on Ward Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community
More informationFor the Patient: ACTW Other names: BRAJACTW
For the Patient: ACTW Other names: BRAJACTW A Doxorubicin (ADRIAMYCIN ) C Cyclophosphamide T Paclitaxel (TAXOL ) weekly Uses: BRAJACTW is a drug treatment given after breast cancer surgery (called adjuvant
More informationGUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION
GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,
More informationVinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial
Original article Annals of Oncology 14: 699 703, 2003 DOI: 10.1093/annonc/mdg199 Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II
More informationFOLFIRINOX (pancreas)
FOLFIRINOX (pancreas) Indication First or second line chemotherapy for metastatic pancreatic cancer. Eligible patients must be
More information1 Principles of Chemotherapy
1 Principles of Chemotherapy Angela Houlston The history of the development of chemotherapy Chemotherapy is the term given to refer to any drug or chemical treatment used to treat any disease. Cytotoxic
More informationWARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS,
Celgene Corporation 86 Morris Avenue Summit, New Jersey 07901 Tel 908-673-9000 Fax 908-673-9001 October 2012 NEW Indication Announcement for ABRAXANE for Injectable Suspension (paclitaxel protein-bound
More informationDocetaxel. Class: Antineoplastic agent, Antimicrotubular, Taxane derivative.
Docetaxel Class: Antineoplastic agent, Antimicrotubular, Taxane derivative. Indications: -Breast cancer: -Non small cell lung cancer -Prostate cancer -Gastric adenocarcinoma _Head and neck cancer Unlabeled
More informationMalignant disease. Chapter 8 TABLE OF CONTENTS. BNF for Pre-reg Humza Yusuf Ibrahim
Chapter 8 Malignant disease TABLE OF CONTENTS Table of Contents... 1 1 Immune system... 2 1.1 Antiproliferative immunosuppressants... 2 1.1.1 Azathioprine... 2 1.1.2 Mycophenolate... 2 1.2 Ciclosporin
More informationIntro to Cancer Therapeutics
An Intro to Cancer Therapeutics Christopher R. Chitambar, MD Professor of Medicine Division of Hematology & Oncology Froedtert and Medical College of Wisconsin Clinical Cancer Center cchitamb@mcw.edu Intro
More informationTreatment results in ALL
Treatment results in ALL Adults Complete remission (CR) 80-85% Leukemia-free survival (LFS) 30-40% Children Complete remission (CR) 95-99% Leukemia-free survival (LFS) 70-80% Combination chemotherapy in
More informationLecture 10: Antimitotic agents cell cycle specific (M phase mainly) 1. Vinca alkaloids. Vincristine (Oncovin):
Lecture 10: Antimitotic agents cell cycle specific (M phase mainly) 1. Vinca alkaloids Vincristine (Oncovin): Uses: Acute leukemia, Hodgkin s lymphoma (part of the MOPP, COPP, BEACOPP regimens); non- Hodgkin
More informationBreast Pathway Group Epirubicin & Cyclophosphamide x 4 followed by Carboplatin & Paclitaxel x 4 for Early Breast Cancer
Breast Pathway Group Epirubicin & Cyclophosphamide x 4 followed by Carboplatin & Paclitaxel x 4 for Early Breast Cancer Indication: Neoadjuvant therapy for patients with BRCA1/2 mutations EC Regimen details:
More informationAnti-cancer Therapy: Antimitotic Agents. Edy Suwarso
Anti-cancer Therapy: Antimitotic Agents Edy Suwarso Discussion Points What is cancer? Mitosis and mitotic checkpoints How deregulation of the above contributes to cancer formation Antimitotic agents as
More informationAnticancer Drugs. University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept.
University of Sulaimani Faculty of Medical Sciences School of Pharmacy Pharmacology & Toxicology Dept. Anticancer Drugs Prepared by: Hussein A. Muhammad MSc cancer Pharmacology hussein.al-barazanchi@kissr.edu.krd
More informationMabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection
MabThera SC. The wait is over. MabThera delivered in just 5 minutes Abbreviated Prescribing Information MabThera 1400 mg solution for subcutaneous (SC) injection (Rituximab) Indications: Indicated in adults
More information2.1 The Importance of Cell Division
2.1 The Importance of Cell Division Functions of cell division Growth Repair Reproduction Growth All organisms begin as a single cell. Cell divisions will increase as an organism s size increases. There
More informationTherapy Side Effects
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Therapy Side Effects Therapy Side Effects Versions 2004 2011: Albert / Bischoff / Costa / Friedrichs / Göhring / Jackisch/
More informationOxaliplatin and Gemcitabine
Oxaliplatin and Gemcitabine Indication Palliative treatment for relapsed metastatic seminoma, non seminoma or combined tumours. ICD-10 codes Codes pre-fixed with C38, C48, C56, C62, C63, C75.3. Regimen
More informationThe bases on complementary strands of DNA bond with each other in a specific way A-T and G-C
1 Bio 1101 Lecture 6 Ch. 8: Cellular Basis of Reproduction 2 3 4 5 6 Cellular Basis of Reproduction & Inheritance In order for an organism to replace dead cells or to grow and produce new cells, existing
More informationMitosis & Meiosis. Practice Questions. Slide 1 / 68. Slide 2 / 68. Slide 3 / Identify two differences between meiosis and mitosis.
New Jersey Center for Teaching and Learning Slide 1 / 68 Progressive Science Initiative This material is made freely available at www.njctl.org and is intended for the non-commercial use of students and
More informationMitosis & Meiosis. Practice Questions. Slide 1 / 68. Slide 2 / 68. Slide 3 / 68. Slide 4 / 68. Slide 6 / 68. Slide 5 / 68
Slide 1 / 68 Slide 2 / 68 New Jersey Center for Teaching and Learning Progressive Science Initiative This material is made freely available at www.njctl.org and is intended for the non-commercial use of
More informationPaclitaxel Gastric Cancer
Systemic Anti Cancer Treatment Handbook Paclitaxel Gastric Cancer PROTOCOL REF: MPHAUGIPAC (Version No: 1.0) Approved for use in: Second line treatment of locally advanced and metastatic gastric / gastro-oesophageal
More informationA PRACTICAL GUIDE TO FELINE CANCER FOR THE CARING CAT OWNER
A PRACTICAL GUIDE TO FELINE CANCER FOR THE CARING CAT OWNER by Dr. Martha S. Gearhart DVM, Diplomate American Board of Veterinary Practitioners PART II: CANCER CHEMOTHERAPY In Part I of this article, the
More informationCellular Reproduction
Section 1: Cellular Growth Section 2: Mitosis and Cytokinesis Section 3: Cell Cycle Regulation Click on a lesson name to select. Section 1 Cellular Growth Ratio of Surface Area to Volume Section 1 Cellular
More informationLecture 11: Antimitotic agents cell cycle specific (M phase mainly) 1. Vinca alkaloids (we will discuss 3) Vincristine (Oncovin):
Lecture 11: Antimitotic agents cell cycle specific (M phase mainly) 1. Vinca alkaloids (we will discuss 3) Vincristine (Oncovin): Uses: Acute leukemia, Hodgkin s lymphoma (part of the MOPP, COPP, BEACOPP
More information(i) List these events in the correct order, starting with D.... (1)... (1)... (1)
Q1. (a) Boxes A to E show some of the events of the cell cycle. A Chromatids seperate B Nuclear envelopes disappears C Cytoplasm divides D Chromosomes condense and become visible E Chromosomes on the equator
More informationCisplatin and Gemcitabine Bladder Cancer: Full and split dose
Systemic Anti Cancer Treatment Protocol Cisplatin and Gemcitabine Bladder Cancer: Full and split dose PROCTOCOL REF: MPHAUROCIG (Version No: 1.0) Approved for use in: Neoadjuvant and palliative indications
More informationStudy No: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More information9/3/2014. Conflict of Interest Disclosures. Learning Objectives. Definitions of Nausea/Vomiting. Definitions of Nausea/Vomiting
Conflict of Interest Disclosures LeAnn B. Norris Teva Pharmaceuticals Last Chance Webinar 2014 Oncology Supportive Care LeAnn B. Norris, PharmD, BCPS, BCOP Assistant Professor South Carolina College of
More informationAnswer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers.
UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2013-2014 CLINICAL THERAPEUTICS 8: ONCOLOGY PHA-MHCY Time allowed: 2 hours Part ONE Answer ALL questions. For each question, there
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs.
More information2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords
Subject Area Weight Keywords Care Continuum 19% Care Continuum Coordination of Care Navigation Psychosocial Symptom Management Health Promotion/Screening and Early Detection Disease Prevention High-Risk
More informationEC (Epirubicin Cyclophosphamide) Adjuvant/Neo-adjuvant regimen
y Systemic Anti Cancer Treatment Protocol EC (Epirubicin Cyclophosphamide) Adjuvant/Neo-adjuvant regimen PROTOCOL REF: MPHAECANBR (Version No: 1.0) Approved for use in: ER positive, HER2 negative ( Luminal
More informationUnit 2: Reproduction and Development. The Cell Cycle
PAGE : 1 The Cell Cycle Cell Cycle: A continuous series of cell growth and division for a cell. All cells go through a cell cycle of some sort. The cell cycle consists of two stages. a. Growth Phase Diagram
More informationExhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A
More informationTCHP Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant Protocol
Systemic Anti Cancer Treatment Protocol TCHP Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant Protocol PROTOCOL REF: MPHATCHP (Version No: 1.0) Approved for use in: Neoadjuvant breast: The neoadjuvant
More informationCELL DIVISION: MITOSIS 27 FEBRUARY 2013
CELL DIVISION: MITOSIS 27 FEBRUARY 2013 Lesson Description In this lesson we: Look at related terminology Discuss the cell cycle Look at the purpose of cell division Consider what is Mitosis Look at the
More informationMASCC Guidelines for Antiemetic control: An update
MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,
More informationFor the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide
For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide Other names: BRLATWAC BR Breast LA Locally Advanced T A C Paclitaxel
More informationDr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013
Dr Ewan Hutchison UK Civil Aviation Authority ICAO European Regional Civil Aviation Medicine Seminar/Workshop București 11-15 November 2013 Types of Cancer Recertification after treatment Certification
More informationFEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel)
FEC-T (Fluorouracil, Epirubicin and Cyclophosphamide and Docetaxel) Indication Adjuvant or neo-adjuvant treatment for high risk early and locally advanced breast cancer. (NICE CG80) ICD-10 codes Codes
More informationBreast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer
Breast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer Indication: Neoadjuvant or adjuvant treatment for patients in whom anthracyclines are contraindicated or inappropriate Regimen
More information